Lasa Supergenerics Limited - Company Profile

Q: Who are the current directors of Lasa Supergenerics Limited?

The current directors of Lasa Supergenerics Limited are Manali Roop Bhagtani, Umesh Shankar Pawar, Mitti Jain, Hardesh Raja Tolani, Ekta Avtar Gurnasinghani, Omkar Herlekar Pravin, Ajay Hareshlal Sukhwani, Mitti Mitesh Jain, Prathmesh Prakash Chalke, Varsha Pravin Joshi, Ketan Bhau Songal, Pravin Gadalya Lachake, Yogesh Hari Ughada, Rekha Hemant Wakh.

It is a pharma public limited company based in Khed, Maharashtra, India, established in 2016.

2016 Khed, Maharashtra, India Active

Last Updated: December 23, 2025

Access Report

About Lasa Supergenerics Limited

Lasa Supergenerics Limited, a active public limited company, was established on 11 March 2016 in Khed, Maharashtra, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: L24233MH2016PLC274202. Registered under ROC Roc Mumbai. it is listed on BSE: 540702 and NSE: LASA. It has an authorized capital of ₹100.33 Cr and a paid-up capital of ₹50.10 Cr.

It upholds a compliant status. In 2023, it reported revenue of ₹131.37 Cr and a net worth of ₹118.29 Cr. Employing 326 professional, Its leadership includes Manali Roop Bhagtani (Director), Umesh Shankar Pawar (Whole-Time Director), Hardesh Raja Tolani (Director). Past directors included Sumant Madhusudan Kharasamble, Pravin Shivdas Herlekar, Manali Roop Bhagtani. It holds no open charges and ₹84.64 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. C-4, C-4/1, Midc Lote Parshuram Industrial Area, Tal -Khe, D,, Khed, Maharashtra, 415722.

Company Details

CIN/LLPIN
L24233MH2016PLC274202
Registration Number
274202
Incorporation Date
11 March 2016
Authorized Capital
₹100.33 Cr
Paid-Up Capital
₹50.10 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 540702, NSE: LASA)
Company Status
Active

Key Metrics

Authorised Capital ₹ 100.33 Cr as on 23-12-2025
Paid Up Capital ₹ 50.10 Cr as on 23-12-2025
Company Age 10 Year, 1 Month
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 84.64 Cr as on 23-12-2025
Revenue Growth **** -4.24% (FY 2023)
Profit Growth **** -619.57% (FY 2023)
Ebitda **** -142.18% (FY 2023)
Net Worth -20.42% (FY 2023)
Total Assets -17.75% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Lasa Supergenerics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Lasa Supergenerics Limited?

Current Directors

Name	Designation	Appointment Date	Status
Manali Roop Bhagtani	Director	15 May 2018	Current
Umesh Shankar Pawar	Whole-Time Director	08 Mar 2024	Current
Hardesh Raja Tolani	Director	02 May 2017	Current
Ekta Avtar Gurnasinghani	Director	02 May 2017	Current
Omkar Herlekar Pravin	Managing Director	11 Mar 2016	Current
Ajay Hareshlal Sukhwani	Director	02 May 2017	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Whole-Time Director	16 Jun 2018	Past
Pramod Abcsdd	Director	02 May 2017	Past
Pramod Abcsdd	Director	12 Feb 2018	Past
Pramod Abcsdd	Cfo	25 Apr 2024	Past
Pramod Abcsdd	Additional Director	15 May 2018	Past
Pramod Abcsdd	Director	02 May 2017	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lasa Supergenerics.

Lasa Supergenerics Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.24% decrease. The company also saw a substantial fall in profitability, with a 619.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.42%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-4.24%

*******

Revenue from Operations

*******

-5.51%

*******

Total Assets

*******

-17.75%

*******

Profit or Loss

*******

-619.57%

*******

Net Worth

*******

-20.42%

*******

EBITDA

*******

-142.18%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lasa Supergenerics?

In 2023, Lasa Supergenerics had a promoter holding of 53.65% and a public holding of 46.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹846,400,000.00

Charges Breakdown by Lending Institutions

Axis Bank Limited : 76.79 Cr
Others : 7.85 Cr

Latest Charge Details

Date	Lender	Amount	Status
26 Apr 2018	Others	₹6.03 Cr	Satisfied
31 Mar 2018	Others	₹1.82 Cr	Satisfied
28 Nov 2012	Axis Bank Limited	₹76.79 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Lasa Supergenerics?

Lasa Supergenerics has a workforce of 326 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Lasa Supergenerics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lasa Supergenerics's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lasa Supergenerics

Recent Activity within the Organization

Annual General Meeting

Progress on Lasa Supergenerics Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
30 Sep 2025
Director Appointment

Ketan Bhau Songal was appointed as a Director was appointed as a Director on 04 Aug 2025 & has been associated with this company since 9 months 4 days . was recorded as a recent event.
04 Aug 2025
Director Appointment

The activity Pravin Gadalya Lachake was appointed as a Director was appointed as a Director on 04 Aug 2025 & has been associated with this company since 9 months 4 days . was completed.
04 Aug 2025
Director Appointment

The activity Yogesh Hari Ughada was appointed as a Director was appointed as a Director on 04 Aug 2025 & has been associated with this company since 9 months 4 days . was completed.
04 Aug 2025
Director Appointment

The activity Rekha Hemant Wakh was appointed as a Director was appointed as a Director on 04 Aug 2025 & has been associated with this company since 9 months 4 days . was completed.
04 Aug 2025
Director Appointment

The activity Prathmesh Prakash Chalke was appointed as a Additional Director was appointed as a Additional Director on 21 May 2025 & has been associated with this company since 11 months 18 days . was completed.
21 May 2025

Explore recent activity and updates - View Recent Activity